US 12,728,147 B2
Composition for preventing or treating inflammatory disease comprising hydrolysis extract of pulsatilla koreana and anemone raddeana as active ingredient
Soong Jin Kim, Goyang-si Gyeonggi-do (KR); and Yu Yeon Roh, Seongnam-si Gyeonggi-do (KR)
Assigned to Ju Youn Back, Seoul (KR)
Appl. No. 18/000,714
Filed by Ju Youn Back, Seoul (KR)
PCT Filed Jun. 4, 2021, PCT No. PCT/KR2021/007047
§ 371(c)(1), (2) Date Dec. 5, 2022,
PCT Pub. No. WO2021/246833, PCT Pub. Date Dec. 9, 2021.
Claims priority of application No. 10-2020-0068577 (KR), filed on Jun. 5, 2020.
Prior Publication US 2023/0210933 A1, Jul. 6, 2023
Int. Cl. A61K 36/71 (2006.01); A61K 45/06 (2006.01); A61P 29/00 (2006.01)
CPC A61K 36/71 (2013.01) [A61K 45/06 (2013.01); A61P 29/00 (2018.01); A61K 2236/19 (2013.01); A61K 2236/333 (2013.01)] 6 Claims
 
1. A method for treating an inflammatory disease in a subject in need thereof, comprising administering to the subject an effective amount of a composition comprising a water-hydrolysis fermentation product of a ground material of Anemone raddeana, Pulsatilla chinensis, or Pulsatilla cernua;
optionally, an organic solvent extract of Pulsatilla koreana; and
at least one angiogenesis inhibitor selected from the group consisting of organic solvent extract of Adonis amurensis, Glycyrrhiza uralensis and deoxypodophyllotoxin (DPT).